MedPath

Effect of Home-Based Care on Movement and Quality of Life in People with Early Parkinson’s Disease

Not yet recruiting
Conditions
Parkinsons disease,
Registration Number
CTRI/2025/05/087938
Lead Sponsor
MGM Institute of Health Sciences, Navi Mumbai
Brief Summary

Present study aims to evaluate the effectiveness of a structured Home-Based Rehabilitation program in improving cognitive function, motor function, non-motor symptoms, and quality of life in individuals with early-stage Parkinson’s disease (PD). As part of the study, screening for Parkinson’s disease will be  conducted among 33,972 elderly individuals (aged 45 years and above) in Panvel Taluka, Raigad District, Maharashtra, to identify early-stage PD cases. Eligible participants will undergo a standardized Home-Based Rehabilitation protocol, designed to address both motor and non-motor aspects of Parkinson’s disease. The study will assess and compare physical function, cognitive performance, symptom severity, and quality of life before and after the intervention. In addition, the study aims to raise awareness among the population about the benefits of Home-Based Rehabilitation and encourage its adoption for managing early Parkinson’s disease in home settings.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
68
Inclusion Criteria

Both male and female population, age 45 years and above will be included in the screening part of the study Both male and female population, age 45 years and above in the early phase Parkinson’s disease who are able to walk for 10 minutes will be included in the study.

Exclusion Criteria
  • Individuals who have experienced recent trauma eg-fractures or trauma to the head (within the last three months), those with mild cognitive impairment or delirium, and individuals with autoimmune or other neurological disorders that could impede physical activity, such as stroke, traumatic brain injury, or spinal cord injury.
  • Additionally, participants with cognitive issues that hinder their ability to comprehend instructions (Montreal Cognitive Assessment scores below 10), those with psychological disorders affecting their understanding, individuals with severe dementia, and those already undergoing any form of rehabilitation for Parkinson’s disease will also be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Movement Disorder Society Unified Parkinsons disease Rating Scale MDS-UPDRSBaseline,12 weeks,24 weeks,36 weeks and 52 weeks for follow up
Secondary Outcome Measures
NameTimeMethod
IPAQWHOQOL-BREF

Trial Locations

Locations (1)

MGM Hospital

🇮🇳

Raigarh, MAHARASHTRA, India

MGM Hospital
🇮🇳Raigarh, MAHARASHTRA, India
Dr Shrutika Parab PT
Principal investigator
09969402471
sparab@mgmsopnm.edu.in

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.